Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


CLINICAL IMPLICATIONS OF NIVOLUMAB IN CANCER IMMUNOTHERAPY

  • In: Poster Session
  • At: Düsseldorf (Germany) (2015)
  • Type: Poster
  • By: KUCUK, Esra (Hacettepe University Faculty of Pharmacy, Clinical Pharmacy, Ankara, Turkey)
  • Co-author(s): Esra KUCUK
    Ecz. Burcu Kelleci, Hacettepe Universitesi Eczacilik Fakultesi Klinik Eczacilik Anabilim Dali
  • Abstract:

    A cancer treatment recently focuses on immunotherapy such as nivolumab, ipilimumab and pembrolizumab.

    We searched through the Pub-Med database (between 2010-2015) by using nivolumab and immunotherapy as keywords.

    Nivolumab is administered via iv infusion over an hour at the dose of 2-3mg/kg for every 2-3 weeks. Drug must be constituted with 0,9%

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses